INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 16 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $895,000 | – | 100,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,724,283 | $17,231,000 | 2.81% |
| Avoro Capital Advisors LLC | 2,195,705 | $13,943,000 | 0.67% |
| MEITAV INVESTMENT HOUSE LTD | 1,605,940 | $10,156,000 | 0.52% |
| CAXTON CORP | 64,280 | $395,000 | 0.43% |
| Cormorant Asset Management, LP | 773,816 | $4,894,000 | 0.36% |
| SECTORAL ASSET MANAGEMENT INC | 451,252 | $2,854,000 | 0.31% |
| Anson Funds Management LP | 50,000 | $316,000 | 0.24% |
| Migdal Insurance & Financial Holdings Ltd. | 522,067 | $3,302,000 | 0.08% |
| MENTA CAPITAL LLC | 26,959 | $171,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,725,000 | $10,911,000 | 0.02% |